A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic.

MLA

Cohen, Joseph R., et al. “A High Threshold of Biotherapeutic Aggregate Numbers Is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic.” Pharmaceutical Research, vol. 41, no. 4, Apr. 2024, pp. 651–72. EBSCOhost, https://doi.org/10.1007/s11095-024-03678-2.

APA

Cohen, J. R., Brych, S. R., Prabhu, S., Bi, V., Elbaradei, A., Tokuda, J. M., Xiang, C., Hokom, M., Cui, X., Ly, C., Amos, N., Sun, J., Calamba, D., Herskovitz, J., Capili, A., Nourbakhsh, K., Merlo, A., Carreon, J., Wypych, J., & Narhi, L. O. (2024). A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic. Pharmaceutical Research, 41(4), 651–672. https://doi.org/10.1007/s11095-024-03678-2

Chicago

Cohen, Joseph R., Stephen R. Brych, Siddharth Prabhu, Vivian Bi, Ahmed Elbaradei, Joshua M. Tokuda, Cathie Xiang, et al. 2024. “A High Threshold of Biotherapeutic Aggregate Numbers Is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic.” Pharmaceutical Research 41 (4): 651–72. doi:10.1007/s11095-024-03678-2.